Miikana Therapeutics' Acquisition

Miikana Therapeutics was acquired by CASI Pharmaceuticals on January 13, 2006.

Miikana has built an oncology pipeline through a strategy that included both in-licensing clinical and preclinical compounds with distinct mechanisms of action, and generating medicinal chemistry-driv…

Articles about Miikana Therapeutics' Acquisition: